BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38495241)

  • 1. Levetiracetam-Mediated Drug-Induced Liver Injury - A Rare Presentation and Review of Literature.
    Jain RS; Srivastava T; Sharma P; Pemawat A
    Ann Indian Acad Neurol; 2024; 27(1):87-90. PubMed ID: 38495241
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the clinical characteristics of the liver injury induced by levetiracetam.
    Sun W; He Y; Li Z; Wang C
    J Pharm Pharmacol; 2022 Mar; 74(3):409-414. PubMed ID: 35089342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam-Induced Hepatic Dysfunction.
    Gayatri P; Selvam MM; Sreeharsha SV
    Neurol India; 2020; 68(4):910-912. PubMed ID: 32859841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam-Induced Skin Hyperpigmentation: An Extremely Rare Undesirable Side Effect.
    Algahtani H; Marghalani S; Satti M; Shirah B
    J Epilepsy Res; 2017 Dec; 7(2):106-108. PubMed ID: 29344468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Levetiracetam causing acute liver failure complicating post-operative management in a neurosurgical patient.
    Jayashankar S; Munakomi S; Sayeerajan V; Kafle P; Chaudhary P; Thingujam J; Poudel D; Cherian I
    F1000Res; 2019; 8():187. PubMed ID: 30984385
    [No Abstract]   [Full Text] [Related]  

  • 6. A Rare Presentation of Levetiracetam-Induced Torsades De Pointes.
    Mann H; Kusayev J; Pandey S; Aryal B; Solaimanzadeh I
    Cureus; 2023 Jun; 15(6):e40866. PubMed ID: 37492848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam-induced transaminitis in a young male with traumatic brain injury.
    Rachamallu V; Song MM; Reed JM; Aligeti M
    Oxf Med Case Reports; 2017 Nov; 2017(11):omx067. PubMed ID: 29744119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suspected Levetiracetam-Induced Acute Rhabdomyolysis in a Patient With Retinoblastoma: A Case Report and Literature Review.
    Alshehabi KM; Askandarani S; Alkhalifah ZA
    Cureus; 2022 May; 14(5):e25183. PubMed ID: 35747052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable levetiracetam-related serum alkaline phosphatase elevation.
    Xiong N; Hou L; Lu N; Mohamed AA; Wang T; Huang Y
    BMC Neurol; 2012 Sep; 12():97. PubMed ID: 22994584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam-induced rage and suicidality: Two case reports and review of literature.
    Molokwu OA; Ezeala-Adikaibe BA; Onwuekwe IO
    Epilepsy Behav Case Rep; 2015; 4():79-81. PubMed ID: 26543810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rare Case of Drug-Induced Liver Injury Caused by Levetiracetam.
    Kawaguchi T; Tominaga T
    Asian J Neurosurg; 2019; 14(3):878-882. PubMed ID: 31497118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome.
    Gómez-Zorrilla S; Ferraz AV; Pedrós C; Lemus M; Peña C
    Ann Pharmacother; 2012; 46(7-8):e20. PubMed ID: 22764327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam-induced thrombocytopenia in a patient with status epilepticus.
    Kim J; Shin JW
    Epileptic Disord; 2017 Mar; 19(1):104-108. PubMed ID: 28202425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare Red Rashes: A Case Report of Levetiracetam-Induced Cutaneous Reaction and Review of the Literature.
    Jones RT; Evans W; Mersfelder TL; Kavanaugh K
    Am J Ther; 2016; 23(3):e944-6. PubMed ID: 25259954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam Liver Injury: A Benign Antiepileptic Agent?
    Hegazy Y; Axley P; Lee G; Gray M
    ACG Case Rep J; 2023 Mar; 10(3):e01003. PubMed ID: 36936131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should Levetiracetam or Phenytoin Be Used for Posttraumatic Seizure Prophylaxis? A Systematic Review of the Literature and Meta-analysis.
    Khan NR; VanLandingham MA; Fierst TM; Hymel C; Hoes K; Evans LT; Mayer R; Barker F; Klimo P
    Neurosurgery; 2016 Dec; 79(6):775-782. PubMed ID: 27749510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of apoptotic cell death on liver and kidney tissues following administration of levetiracetam during prenatal period.
    Tekcan A; Tural S; Elbistan M; Guvenc T; Ayas B; Kara N
    J Matern Fetal Neonatal Med; 2017 Feb; 30(4):420-423. PubMed ID: 27255296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam in toxic seizures.
    Lee T; Warrick BJ; Sarangarm P; Alunday RL; Bussmann S; Smolinske SC; Seifert SA
    Clin Toxicol (Phila); 2018 Mar; 56(3):175-181. PubMed ID: 28753046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute liver failure associated with levetiracetam and lacosamide combination treatment for unspecified epileptic disorder.
    Gutiérrez-Grobe Y; Bahena-Gonzalez JA; Herrera-Gomar M; Mendoza-Diaz P; García-López S; González-Chon O
    Case Rep Emerg Med; 2013; 2013():634174. PubMed ID: 24027645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
    Cotton BA; Kao LS; Kozar R; Holcomb JB
    J Trauma; 2011 Aug; 71(2):375-9. PubMed ID: 21825941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.